Psychiatry and critical-appraisal clinicians get a careful approach to attention problems first reported in adulthood. Developmental history and collateral information help identify overlooked childhood ADHD, while sleep disorders, substance use, mood disorders, obsessive symptoms and psychosis remain important alternative explanations.

Psychiatry and primary-care clinicians get a diagnostic framework for adult inattention that starts with childhood-onset symptoms and current functional impairment. Sleep apnoea, sleep deprivation, substance use, concussion, menopause, social-media overuse and increased occupational demands remain important alternatives, while collateral history can strengthen uncertain retrospective accounts.

Psychiatry, mental-health and medical-education clinicians get a practical introduction to dialectical behaviour therapy for borderline personality disorder. The acceptance-change dialectic, biosocial formulation, diary cards, behavioural chain analysis, target hierarchy and skills training are linked to the management of self-harm, suicidal behaviour and pervasive emotion dysregulation.

Psychiatry and primary-care clinicians get a sex-aware prescribing review covering urinary symptoms, sexual dysfunction, prolactin elevation, bone health, sedation and substance-related harm. It also highlights sleep-apnoea screening when poor concentration or ADHD-like symptoms coexist with snoring, daytime sleepiness or witnessed apnoeas.

Psychiatry, obstetrics and gynaecology, respiratory and primary-care clinicians get a midlife mental-health prescribing update. Perimenopausal depression, bipolar caution, vasomotor symptoms, HRT referral, ADHD symptoms, sleep apnoea screening, atomoxetine, gabapentin, melatonin and adjuncts such as clonidine, L-methylfolate and saffron are kept in view.

Psychiatry, primary-care, obstetrics and sexual-health clinicians get a prescribing update on cyclical symptom worsening, contraception and psychiatric medication. It separates premenstrual syndrome from relapse, highlights PMDD treatment options, and keeps lamotrigine, CYP3A4 inducers, pregnancy, HRT and contraceptive effectiveness in view.

Psychiatry, obstetrics and gynaecology, and endocrinology clinicians get sex-specific prescribing considerations. Valproate’s fetal and endocrine risks, lower zolpidem dose limits, atypical depression, premenstrual symptom changes, pregnancy and breastfeeding are central to the discussion.

Psychiatry, general practice and emergency clinicians get a balanced harm-reduction frame for psilocybin. It separates possible effects in depression or terminal illness anxiety from treatment-resistant uncertainty, contraindications, serotonergic medicine review, supervised dosing, integration therapy and persistent perceptual disturbance.

Trauma presentations with flashbacks, nightmares, persistent anxiety or low self-esteem may need more than symptom labelling. The EMDR guide is useful for understanding stabilisation, readiness for reprocessing, bilateral stimulation and the eight-phase model before considering accredited training.

Autistic young people may carry suicide risk even when supervision, routine or communication differences make distress harder to read. The emphasis is concrete language, processing time, collateral history and safety planning that includes sensory triggers, access to lethal means and family roles.